The prognostic factors of cryptococcal meningitis in HIV-negative patients

Journal of Hospital Infection

Volumn 42, Issue 4, 1999, Pages 313-320

  Lu, C H ^a   Chang, W N ^a   Chang, H W ^b   Chuang, Y C ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Cryptococcal meningitis; Prognostic factors

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIGEN; FLUCONAZOLE; GLUCOSE; LACTIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; CONSCIOUSNESS; EARLY DIAGNOSIS; FEMALE; FUNGAL MENINGITIS; HUMAN; HYDROCEPHALUS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REGRESSION ANALYSIS; SEIZURE; VASCULITIS;

EID: 0032814185     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1998.0610     Document Type: Article

References (25)

1. Zuger A., Louie E., Holzman R. S., Simberkoff M. S. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 104:1986;234-240.
2. Eiser A. R., Neff M. S., Slifkin R. F. Cure of Cryptococcemia in an immunocompromised patient with lupus nephritis. Am J Nephrol. 2:1982;95-97.
3. Khan M. A., Sbar S. Cryptococcal meningitis in steroid-treated systemic lupus erythematosus. Postgrad Med J. 51:1975;660-662.
4. Hellmann D. B., Petri M., Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine. 66:1987;341-348.
5. Kaplan M. H., Rosen P. P., Armstrong D. Cryptococcosis in a cancer hospital: clinical and pathological correlates in forty-six patients. 1977;Cancer. p. 2265-2274.
6. Khanna N., Chandramuki A., Desai A., Ravi V. Cryptococcal infections of the CNS: an analysis of predisposing factors, laboratory findings and outcome in patients from South India with special reference to HIV infection. J Med Micro. 45:1996;376-379.
7. Bennett J. E., Dismukes W. E., Duma R. J. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med. 301:1979;126-131.
8. Speller D. C. E., Fakunle F., Cairns S. A., Stephens M. Cryptococcal meningitis complicating systemic lupus erythematosus: two patients treated with flucytosine and amphotericin B. J Clin Path. 30:1977;254-261.
9. Lentnek A., Sande M. A., Whitley R. J., McCracken G. H., Scheld W. M. Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis. Clin Infect Dis. 15(suppl 1):1992;S189-94.
10. Graybill J. R. New antifungal agents. Eur J Clin Microbiol Infect Dis. 8:1989;402-412.
11. Berry A. J., Rinaldi M. G., Craybill J. R. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother. 36:1992;690-692.
12. Powderly W. G. Therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 14(Suppl 1):1992;S54-S59.
13. Bolignano G., Chindermi G., Criseo G. Cryptococcal meningoencephalitis in a patient with Hodgkin's lymphoma: successful treatment with fluconazole. Mycoses. 34:1991;63-65.
14. Larsen R. A., Leal M. A. E., Chan L. S. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann Intern Med. 113:1990;183-187.
15. Dismukes W. E., Cloud G., Gallis H. A. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 317:1987;334-341.
16. Snow R. M., Dismukes W. E. Cryptococcal meningitis. Arch Intern Med. 135:1975;1155-1157.
17. Stern J. J., Pietroski N. A., Buckley R. M., Braffman M. N., Rinaldi M. G. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients. Ann Pharmacother. 26:1992;876-882.
18. Saag M. S., Powderly W. G., Cloud G. A. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med. 326:1992;83-89.
19. Diamond R. D., Bennett J. E. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med. 80:1974;176-181.
20. Gal A. A., Evans S., Meyer P. R. The clinical laboratory evaluation of cryptococcal infections in the acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis. 7:1987;249-254.
21. White M., Cirrincione C., Blevins A., Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis. 165:1992;960-963.
22. Johnston S. R. D., Corbett O., Foster S., Ash S., Cohen J. Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. J Infect Dis. 24:1992;185-189.
23. Li P. K. T., Lai K. N. Amphotericin B induced ocular toxicity in cryptococcal meningitis. Br J Ophthalmol. 73:1989;397-398.
24. Tjia D., Yeow Y. K., Tan C. B. Cryptococcal meningitis. J Neurol Neurosurg Psychiatry. 48:1985;853-858.
25. SAS, 1990. SAS User's Guide, SAS Statistical Institute, Cary, North, Carolina.